NCT03317730View on ClinicalTrials.gov

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 4, 2019

Study Completion Date

November 17, 2020

Conditions
Locally Advanced Head and Neck Cancer
Interventions
DRUG

Xtampza ER

Xtampza ER is a wax microsphere formulation of oxycodone that results in a nearly identical pharmacokinetic profile regardless of whether the capsule is intact when ingested or if ingested via enteral feeding tube as opposed to by mouth.

Trial Locations (1)

35233

Hazelrig-Salter Radiation Oncology Center, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03317730 - Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter